Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.
暂无分享,去创建一个
Y. Pommier | J. Doroshow | Shar-yin N. Huang | S. Takeda | J. Murai | B. Das | A. Renaud | Yiping Zhang | J. Ji | Amélie Renaud
[1] C. Shapiro,et al. Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells , 2012, Breast Cancer Research and Treatment.
[2] Guy G. Poirier,et al. PARP-1 Activation—Bringing the Pieces Together , 2012, Science.
[3] J. Pascal,et al. Structural Basis for DNA Damage–Dependent Poly(ADP-ribosyl)ation by Human PARP-1 , 2012, Science.
[4] B. McKay,et al. Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53 , 2012, EMBO molecular medicine.
[5] J. Doroshow,et al. Advances in using PARP inhibitors to treat cancer , 2012, BMC Medicine.
[6] J. Weigelt,et al. Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors , 2012, Nature Biotechnology.
[7] Samuel H. Wilson,et al. Increased PARP-1 Association with DNA in Alkylation Damaged, PARP-Inhibited Mouse Fibroblasts , 2012, Molecular Cancer Research.
[8] K. Flatten,et al. Enhanced Killing of Cancer Cells by Poly(ADP-ribose) Polymerase Inhibitors and Topoisomerase I Inhibitors Reflects Poisoning of Both Enzymes* , 2011, The Journal of Biological Chemistry.
[9] L. Rubinstein,et al. Modeling Pharmacodynamic Response to the Poly(ADP-Ribose) Polymerase Inhibitor ABT-888 in Human Peripheral Blood Mononuclear Cells , 2011, PloS one.
[10] W. Xiao,et al. Roles of sequential ubiquitination of PCNA in DNA‐damage tolerance , 2011, FEBS letters.
[11] K. Myung,et al. Dynamic regulation of PCNA ubiquitylation/deubiquitylation , 2011, FEBS letters.
[12] Y. Pommier,et al. Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas. , 2011, Cancer research.
[13] Thomas Helleday,et al. The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings , 2011, Molecular oncology.
[14] E. Kolker,et al. Competition between PARP-1 and Ku70 control the decision between high-fidelity and mutagenic DNA repair. , 2011, DNA repair.
[15] Scott H. Kaufmann,et al. Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells , 2011, Proceedings of the National Academy of Sciences.
[16] Y. Pommier,et al. Poly(ADP-ribose) polymerase and XPF–ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells , 2011, Nucleic acids research.
[17] Cristina Al-Khalili Szigyarto,et al. Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate , 2010, Nucleic acids research.
[18] Samuel H. Wilson,et al. Alkylation DNA damage in combination with PARP inhibition results in formation of S-phase-dependent double-strand breaks. , 2010, DNA repair.
[19] W. Kraus,et al. The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. , 2010, Molecular cell.
[20] A. D’Andrea,et al. Susceptibility pathways in Fanconi's anemia and breast cancer. , 2010, The New England journal of medicine.
[21] S. Kaufmann,et al. PARP inhibition: PARP1 and beyond , 2010, Nature Reviews Cancer.
[22] A. Ashworth,et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. , 2009, The New England journal of medicine.
[23] A. Ashworth,et al. Targeted therapy for cancer using PARP inhibitors. , 2008, Current opinion in pharmacology.
[24] J. Masson,et al. PARP1-dependent Kinetics of Recruitment of MRE11 and NBS1 Proteins to Multiple DNA Damage Sites* , 2008, Journal of Biological Chemistry.
[25] M. Hottiger,et al. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. , 2008, Frontiers in bioscience : a journal and virtual library.
[26] Heinrich Leonhardt,et al. Feedback-regulated poly(ADP-ribosyl)ation by PARP-1 is required for rapid response to DNA damage in living cells , 2007, Nucleic acids research.
[27] J. Weinstein,et al. Depicting combinatorial complexity with the molecular interaction map notation , 2006, Molecular systems biology.
[28] Alan Ashworth,et al. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. , 2006, Cancer research.
[29] V. Schreiber,et al. Poly(ADP-ribose): novel functions for an old molecule , 2006, Nature Reviews Molecular Cell Biology.
[30] V. Schreiber,et al. Parp‐1 protects homologous recombination from interference by Ku and Ligase IV in vertebrate cells , 2006, The EMBO journal.
[31] C. Godon,et al. Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis , 2006, Molecular Cancer Therapeutics.
[32] T. Helleday,et al. Spontaneous Homologous Recombination Is Induced by Collapsed Replication Forks That Are Caused by Endogenous DNA Single-Strand Breaks , 2005, Molecular and Cellular Biology.
[33] Samuel H. Wilson,et al. Poly(ADP-ribose) Polymerase Activity Prevents Signaling Pathways for Cell Cycle Arrest after DNA Methylating Agent Exposure* , 2005, Journal of Biological Chemistry.
[34] Thomas Helleday,et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase , 2005, Nature.
[35] Alan Ashworth,et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.
[36] H. Kitao,et al. Similar Effects of Brca2 Truncation and Rad51 Paralog Deficiency on Immunoglobulin V Gene Diversification in DT40 Cells Support an Early Role for Rad51 Paralogs in Homologous Recombination , 2005, Molecular and Cellular Biology.
[37] P. Calsou,et al. Involvement of Poly(ADP-ribose) Polymerase-1 and XRCC1/DNA Ligase III in an Alternative Route for DNA Double-strand Breaks Rejoining* , 2004, Journal of Biological Chemistry.
[38] Mitsuko Masutani,et al. A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. , 2003, Nucleic acids research.
[39] P. Chambon,et al. Functional interaction between PARP‐1 and PARP‐2 in chromosome stability and embryonic development in mouse , 2003, EMBO Journal.
[40] M. Yamaizumi,et al. RAD18 and RAD54 cooperatively contribute to maintenance of genomic stability in vertebrate cells , 2002, The EMBO journal.
[41] P. Dollé,et al. Poly(ADP-ribose) Polymerase-2 (PARP-2) Is Required for Efficient Base Excision DNA Repair in Association with PARP-1 and XRCC1* , 2002, The Journal of Biological Chemistry.
[42] Y. Pommier,et al. Conversion of Topoisomerase I Cleavage Complexes on the Leading Strand of Ribosomal DNA into 5′-Phosphorylated DNA Double-Strand Breaks by Replication Runoff , 2000, Molecular and Cellular Biology.
[43] T. Lindahl,et al. Quality control by DNA repair. , 1999, Science.
[44] F. Apiou,et al. PARP-2, A Novel Mammalian DNA Damage-dependent Poly(ADP-ribose) Polymerase* , 1999, The Journal of Biological Chemistry.
[45] M. Masson,et al. XRCC1 Is Specifically Associated with Poly(ADP-Ribose) Polymerase and Negatively Regulates Its Activity following DNA Damage , 1998, Molecular and Cellular Biology.
[46] T. Lindahl,et al. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. , 1995, Trends in biochemical sciences.
[47] Masahiko S. Satoh,et al. Role of poly(ADP-ribose) formation in DNA repair , 1992, Nature.
[48] Michael Gill,et al. ADP-ribosylation in mammalian cell ghosts. Dependence of poly(ADP-ribose) synthesis on strand breakage in DNA. , 1980, The Journal of biological chemistry.
[49] B. Durkacz,et al. (ADP-ribose)n participates in DNA excision repair , 1980, Nature.
[50] M. Jacobson,et al. Poly(ADP-ribose) levels in carcinogen-treated cells , 1979, Nature.